People
Findacure co-founder will apply extensive drug repurposing and rare disease expertise to progress Healx’s drug candidates into the clinic.
Chants of “H.R. 3” broke out in the House of Representatives chamber during Tuesday night’s State of the Union Address as Democratic lawmakers urged action on the bill passed late last year that could impact the price of prescription medications paid for by government-funded health programs.
BryoLogyx Inc., announced that David Crockford has joined the Company as vice president of clinical development and logistics, a new position.
Pappas Capital, a leading investor in early-stage life sciences companies, has appointed Karen LeVert as Venture Partner to help lead the expansion of the firm’s Specialized Fund Management business, with a focus on identifying attractive investment opportunities in agricultural and other related technologies.
PhoreMost Limited, the UK-based biopharmaceutical company dedicated to drugging ‘undruggable’ disease targets, announced it has made two appointments to strengthen its leadership team, as the Company positions itself for growth.
Polarean Imaging plc announces that Jonathan Allis, Non-Executive Director, has assumed the role of Chairman with immediate effect.
In honor of Black History Month, BioSpace chose to highlight 10 African American leaders in the life sciences, individuals who have prominent roles in the life sciences and biopharmaceutical industry.
Forbion, a leading European life sciences venture capital firm, announces that Dr. John Montana has joined Forbion as Operating Partner, effective 1st January 2020.
Pharma and biotech companies strengthen their leadership teams and boards with this week’s Movers & Shakers.
The newly-released BIO report analyzed data from a survey of nearly 100 BIO member companies that was conducted online from May to June 2019.
PRESS RELEASES